Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers.
Maia AT, Antoniou AC, O'Reilly M, Samarajiwa S, Dunning M, Kartsonaki C, Chin SF, Curtis CN, McGuffog L, Domchek SM; EMBRACE; Easton DF, Peock S, Frost D, Evans DG, Eeles R, Izatt L, Adlard J, Eccles D; GEMO Study Collaborators; Sinilnikova OM, Mazoyer S, Stoppa-Lyonnet D, Gauthier-Villars M, Faivre L, Venat-Bouvet L, Delnatte C, Nevanlinna H, Couch FJ, Godwin AK, Caligo MA; SWE-BRCA; Barkardottir RB; kConFab Investigators; Chen X, Beesley J, Healey S, Caldas C, Chenevix-Trench G, Ponder BA.
Maia AT, et al. Among authors: caligo ma.
Breast Cancer Res. 2012 Apr 18;14(2):R63. doi: 10.1186/bcr3169.
Breast Cancer Res. 2012.
PMID: 22513257
Free PMC article.